Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930293 · ClinicalTrials.gov registry record · NA
Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00930293: Completed NA study, sponsored by University of Pittsburgh.
NCT00930293 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00930293, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
This study will examine the feasibility and efficacy of a personalized psychotherapy treatment for people with depression and co-occurring anxiety.
Primary Outcome
Depression remission defined as 3 consecutive weeks of HRSD-17 scores that on average, \< or = 7
Interventions
- BEHAVIORAL Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS)
- BEHAVIORAL Brief Supportive Psychotherapy (BSP)
- DRUG Citalopram hydrobromide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2009-07 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT00930293 record still lists
NCT00930293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS) is the first listed.
NCT00930293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00930293 about?
NCT00930293 is a clinical study titled "Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety". This study will examine the feasibility and efficacy of a personalized psychotherapy treatment for people with depression and co-occurring anxiety.
What is the current status of trial NCT00930293?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2009-07. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00930293?
The interventions under investigation include: Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS) (BEHAVIORAL), Brief Supportive Psychotherapy (BSP) (BEHAVIORAL), Citalopram hydrobromide (DRUG).
Who is sponsoring clinical trial NCT00930293?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00930293's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia